Silco Pharmaceuticals Limited (DSE: SILCOPHL)
Health Care · Pharmaceuticals · BD
Tk15.30
-8.38% today · +1.3% 1Y
Silco Pharmaceuticals Limited (DSE: SILCOPHL) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $12.90M.
Over the last twelve months the share price has gained 1.3%, trading between 11.10 and 23.30.
Tweenvest scores Silco Pharmaceuticals Limited across four factors: quality 77/100, value 46/100, growth 0/100, dividend 23/100. Its strongest factor is quality.
SILCOPHL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $12.90M
- Revenue (TTM)
- $3.33M
- P/E
- 46.24
- EPS
- 0.33
- Dividend yield
- 0.72%
- Beta (5Y)
- 0.32
- 52-week high
- Tk23.30
- 52-week low
- Tk11.10
- Avg volume (3M)
- —
- Shares outstanding
- 103.81M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| PT Phapros TbkIDX: PEHA | $13.52M | Rp288.00 | +2.86% |
| Klaria Pharma Holding AB (publ.)OM: KLAR | $13.36M | Skr0.48 | -11.60% |
| Ayr Wellness Inc.CNSX: AYR.A | $13.21M | CA$— | — |
| Indo-Bangla Pharmaceuticals LimitedDSE: IBP | $13.02M | Tk13.80 | -5.48% |
| Anebulo Pharmaceuticals, Inc.OTCPK: ANEB | $12.85M | $0.32 | -1.56% |
| Intravenous Infusions PlcGHSE: IIL | $12.84M | GH₵0.55 | +12.24% |
| FLUENT Corp.CNSX: FNT.U | $12.76M | $0.02 | -20.00% |
| Biogened S.A.WSE: BGD | $12.41M | zł19.90 | +0.51% |
Figures last refreshed Oct 11, 2026.